Can CA-125/CEA ratio be used for the differential diagnosis between ovarian and nonovarian cancers? A research letter. [PDF]
Zanon JR +9 more
europepmc +1 more source
Evaluating pretreatment serum CA-125 levels as prognostic biomarkers in endometrial cancer: a comprehensive meta-analysis. [PDF]
Yu Z, Sun Y, Guo C.
europepmc +1 more source
Nomogram development for predicting ovarian tumor malignancy using inflammatory biomarker and CA-125. [PDF]
Winarno GNA +8 more
europepmc +1 more source
CA 125 for surgico-pathological stage 1 endometrial cancer. [PDF]
Wang PH, Yang ST.
europepmc +1 more source
Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS. [PDF]
Bedia JS +14 more
europepmc +1 more source
Association between CA-125 and post-extubation respiratory failure: a cohort study. [PDF]
Lombuli F, Montes THM, Boniatti MM.
europepmc +1 more source
Evaluation of Serum Cancer Antigen (CA)-125 Levels as a Biomarker for Ovarian Lesions: Correlation With Histopathological Diagnosis and Clinical Outcomes. [PDF]
Patil NJ +4 more
europepmc +1 more source
Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia. [PDF]
Ashi A +7 more
europepmc +1 more source
One-Step Electrochemical Sensing of CA-125 Using Onion Oil-Based Novel Organohydrogels as the Matrices. [PDF]
Er OF, Kivrak H, Alpaslan D, Dudu TE.
europepmc +1 more source
On Whether Ca-125 Is the Answer for Diagnosing Overhydration, Particularly in End-Stage Kidney Disease Patients-A Systematic Review. [PDF]
Nikitiuk BE +4 more
europepmc +1 more source

